Evidence map›Paper›PMID 28487874›Full record

ArticleJournal of renal injury prevention2017

Administration of pentoxifylline to improve anemia of hemodialysis patients.

Heshmatolah Shahbazian, Ali Ghorbani, Azita Zafar-Mohtashami, Abdolreza Balali, Armaghan AleAli, Gholam Reza Lashkarara

Registry-linked trialOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of renal injury prevention, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03800433 (Impact of Pentoxifylline Administration on the Modulation of Hyporesponsiveness to Erythropoietin Stimulating Agents in Hemodialysis Patients), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03800433 early_phase1unknown statusnot on this mapstarted 2019, after this paper: background citation

Impact of Pentoxifylline Administration on the Modulation of Hyporesponsiveness to Erythropoietin Stimulating Agents in Hemodialysis Patients

TypeinterventionalSponsorAin Shams UniversityRan2019 to 2020Enrolled46ConditionsAnemia RenalArmsTrental 400 MG Extended Release Oral Tablet
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Heshmatolah ShahbazianDiabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Ali GhorbaniDiabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Azita Zafar-MohtashamiDepartment of Internal Medicine, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khoramabad, Iran.
Abdolreza BalaliAhvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Armaghan AleAliDiabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Gholam Reza LashkararaLorestan University of Medical Sciences, Khoramabad, Iran.
Ahvaz Jundishapur University of Medical Sciences · IRLorestan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnemiaCytokineEnd-stage renal diseasePentoxifylline

Identifiers

PMID28487874
PMCPMC5414521
OpenAlexW2557541889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.